Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $312.12 million. The enterprise value is $346.90 million.
| Market Cap | 312.12M |
| Enterprise Value | 346.90M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 9.16 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Current Share Class | 9.16M |
| Shares Outstanding | 9.16M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | +6.05% |
| Owned by Insiders (%) | 31.41% |
| Owned by Institutions (%) | 15.45% |
| Float | 3.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 139.70 |
| PS Ratio | 2.90 |
| Forward PS | 3.45 |
| PB Ratio | 44.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 92.53 |
| P/OCF Ratio | 49.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.64, with an EV/FCF ratio of 102.83.
| EV / Earnings | n/a |
| EV / Sales | 3.23 |
| EV / EBITDA | 34.64 |
| EV / EBIT | 52.50 |
| EV / FCF | 102.83 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 6.89.
| Current Ratio | 2.28 |
| Quick Ratio | 1.99 |
| Debt / Equity | 6.89 |
| Debt / EBITDA | 4.83 |
| Debt / FCF | 14.34 |
| Interest Coverage | 0.91 |
Financial Efficiency
Return on equity (ROE) is 2.86% and return on invested capital (ROIC) is 10.02%.
| Return on Equity (ROE) | 2.86% |
| Return on Assets (ROA) | 8.28% |
| Return on Invested Capital (ROIC) | 10.02% |
| Return on Capital Employed (ROCE) | 11.89% |
| Weighted Average Cost of Capital (WACC) | 10.87% |
| Revenue Per Employee | $995,208 |
| Profits Per Employee | -$310,893 |
| Employee Count | 108 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 2.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.98% in the last 52 weeks. The beta is 1.18, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +40.98% |
| 50-Day Moving Average | 24.49 |
| 200-Day Moving Average | 22.46 |
| Relative Strength Index (RSI) | 83.32 |
| Average Volume (20 Days) | 290,415 |
Short Selling Information
The latest short interest is 377,539, so 4.12% of the outstanding shares have been sold short.
| Short Interest | 377,539 |
| Short Previous Month | 361,586 |
| Short % of Shares Out | 4.12% |
| Short % of Float | 10.10% |
| Short Ratio (days to cover) | 5.71 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $107.48 million and -$33.58 million in losses. Loss per share was -$3.89.
| Revenue | 107.48M |
| Gross Profit | 99.87M |
| Operating Income | 10.97M |
| Pretax Income | 625,129 |
| Net Income | -33.58M |
| EBITDA | 10.02M |
| EBIT | 6.61M |
| Loss Per Share | -$3.89 |
Balance Sheet
The company has $13.59 million in cash and $48.37 million in debt, with a net cash position of -$34.77 million or -$3.79 per share.
| Cash & Cash Equivalents | 13.59M |
| Total Debt | 48.37M |
| Net Cash | -34.77M |
| Net Cash Per Share | -$3.79 |
| Equity (Book Value) | 7.02M |
| Book Value Per Share | 0.77 |
| Working Capital | 17.50M |
Cash Flow
In the last 12 months, operating cash flow was $6.32 million and capital expenditures -$2.95 million, giving a free cash flow of $3.37 million.
| Operating Cash Flow | 6.32M |
| Capital Expenditures | -2.95M |
| Depreciation & Amortization | 2.56M |
| Net Borrowing | n/a |
| Free Cash Flow | 3.37M |
| FCF Per Share | $0.37 |
Margins
Gross margin is 92.92%, with operating and profit margins of 10.20% and -31.24%.
| Gross Margin | 92.92% |
| Operating Margin | 10.20% |
| Pretax Margin | 0.58% |
| Profit Margin | -31.24% |
| EBITDA Margin | 9.32% |
| EBIT Margin | 6.15% |
| FCF Margin | 3.14% |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -10.76% |
| FCF Yield | 1.08% |
Analyst Forecast
The average price target for Sanara MedTech is $34.00, which is -0.18% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.00 |
| Price Target Difference | -0.18% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 13.88% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 3.16 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.16 |
| Piotroski F-Score | 5 |